Advanced search
Publication Cover
Expert Review of Neurotherapeutics Volume 15, 2015 - Issue 12
Submit an article Journal homepage
187
Views
3
CrossRef citations to date
0
Altmetric
Drug profiles

Vorapaxar for secondary stroke prevention: perspectives and obstacles

Victor L SerebruanyDepartment of Neurology, Johns Hopkins University, Baltimore, MD, USA
,
Moo Hyun KimCorrespondence[email protected]
,
Seth D FortmannHeartDrug Research Laboratories, Towson, MD, USA
&
Dan F HanleyDepartment of Neurology, Johns Hopkins University, Baltimore, MD, USA
Pages 1377-1382 | Published online: 13 Nov 2015

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Maria Giulia Mosconi, Maurizio Paciaroni & Walter Ageno. (2022) Investigational drugs for ischemic stroke: what’s in the clinical development pipeline for acute phase and prevention?. Expert Opinion on Investigational Drugs 31:7, pages 645-667.
Read now

Articles from other publishers (2)

Qiang Zhang, Jingxiang Pang, Tian-Zhang Wang, Feng Chen, Minghao Shen, Tianyu Li, Yongshuai Chai, Yu-Feng Liang, Jie Sun & Zhushuang Bai. (2023) Organocatalytic enantioselective construction of bicyclic γ-butrolactones. Chinese Chemical Letters 34:7, pages 108121.
Crossref
Rahul Gupta, Muling Lin, Anila Mehta, Surya K. Aedma, Rajendra Shah, Purva Ranchal, Apurva V. Vyas, Shailendra Singh, Bryan Kluck, William G. Combs & Nainesh C. Patel. (2023) Protease-Activated Receptor Antagonist for Reducing Cardiovascular Events – A Review on Vorapaxar. Current Problems in Cardiology 48:3, pages 101035.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.